About This Trial
Real-world effectiveness study of long-acting RSV monoclonal antibody in infants.
Primary Endpoints
- RSV hospitalization rate
- Medically attended RSV
Latest Update
February 2026
First full RSV season data shows 83% reduction in hospitalizations vs historical controls.